ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

France Suspends Sales of Bayer AG (BAY.F)'s Acne Pill Diane 35 After Deaths


1/30/2013 8:10:15 AM

France's health regulator ANSM said on Wednesday it would suspend sales of Bayer acne pill Diane 35 and its generic versions, all also used as a contraceptive, after four deaths over the past 25 years were linked to its use. About 315,000 women used Diane 35 or its generic version in France last year. Bayer officials were not immediately available to comment on the suspension of the drug, which is sold in over 100 countries, typically under brand names including Dianette. The four deaths linked to Diane 35 were due to blood clots, and three other deaths possibly connected to the drug were also linked to other health issues, the agency said. ANSM said it would phase the suspension over three months to allow women to switch to other treatments. Diane 35 reduces acne by regulating hormones and blocking ovulation, and is often prescribed as a contraceptive even though it is not approved for this use.

Read at Reuters
Read at Market Watch
Read at Pharmalot
Read at News Release
 
 Read Article at  Related Companies  News Categories
Bayer AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES